WntResearch announces that the Phase 1b study with Foxy-5 is approved
WntResearch today announces that the Danish regulatory authorities and the ethics committee have approved the protocol for the Phase 1b study with Foxy-5. Thus, the study will start immediately. With the Danish regulatory authorities and the ethics committee having approved the protocol for the previously announced Phase 1b study with Foxy-5, two Danish research centres (Rigshospitalet in Copenhagen and Herlev University Hospital), will now begin recruitment of patients for the study. Furthermore, WntResearch can also announce that Northern Centre for Cancer Care (NCCC) at Freeman